Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 319461 - 319480 out of 495987 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Luxembourg | (L01FX07) blinatumomab | Blincyto (Abacus Medicine) PDRE SOLCC.PERF. 38,5 mcg 1*1 flacon (verre) + 1*1 flacon (verre) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | n/a |
Luxembourg | (L01FX07) blinatumomab | Blincyto PDRE SOLCC.SOL.PERF. 38,5 mcg 1*1 flacon (verre) + 1*1 flacon (verre) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | n/a |
Luxembourg | (L01FX09) mogamulizumab | POTELIGEO SOLCC.DSP. 4 mg / 1 mL 1*1 flacon 5 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Sezary Syndrome; Mycosis Fungoides | n/a |
Luxembourg | (L01FX12) tafasitamab | MINJUVI PDRE SOLCC.PERF. 200 mg 1*1 flacon | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | n/a |
Luxembourg | (L01FX13) enfortumab vedotin | Padcev PDRE SOLCC.PERF. 20 mg 1*1 flacon 10 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | n/a |
Luxembourg | (L01FX13) enfortumab vedotin | Padcev PDRE SOLCC.PERF. 30 mg 1*1 flacon 10 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | n/a |
Luxembourg | (L01FX18) amivantamab | Rybrevant SOLCC.PERF. 350 mg 1*1 flacon 7 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | n/a |
Luxembourg | (L01FX24) teclistamab | TECVAYLI SOL.INJ. 10 mg / 1 mL 1*1 flacon (verre) 3 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01FX24) teclistamab | TECVAYLI SOL.INJ. 90 mg / 1 mL 1*1 flacon (verre) 1,7 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01FY01) pertuzumab and trastuzumab | Phesgo SOL.INJ. 1200 mg / 15 mL + 600 mg / 15 mL 1*1 flacon 15 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01FY01) pertuzumab and trastuzumab | Phesgo SOL.INJ. 600 mg / 10 mL + 600 mg / 10 mL 1*1 flacon 10 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01XA01) cisplatin | CISPLATINE TEVA-1MG/ML SOLCC.PERF. 1 mg / 1 mL 1*1 flacon verre 10 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA02) carboplatin | CARBOSIN SOLCC.PERF. 150 mg / 15 mL 1*1 flacon 15 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA02) carboplatin | CARBOSIN SOLCC.PERF. 50 mg / 5 mL 1*1 flacon 5 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA03) oxaliplatin | ELOXATIN 5 mg/ml SOLCC.PERF. 100 mg / 20 mL 1*1 VIAL 20 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA03) oxaliplatin | ELOXATIN 5 mg/ml SOLCC.PERF. 50 mg / 10 mL 1*1 VIAL 10 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA03) oxaliplatin | OXALIPLATINE TEVA-5MG/ML SOLCC.PERF. 5 mg / 1 mL 1*1 FL. 10 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XA03) oxaliplatin | OXALIPLATINE TEVA-5MG/ML SOLCC.PERF. 5 mg / 1 mL 1*1 FL. 20 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01XC02) rituximab | MABTHERA SOL.PERF. 100 mg 1*2 AMP. 10 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | n/a |
Luxembourg | (L01XC02) rituximab | MABTHERA SOL.PERF. 500 mg 1*1 AMP. 50 ML | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | n/a |